Senseonics Holdings, Inc. Common Stock (SENS) Stock Price
SENSStock
$7.77−8.16%52W
Market Cap$410.83M
P/E—
PEG Ratio—
Div yield—
Beta1.04
SENS Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)5.21%
Price vs S&P 500 (4W)-19.23%
VGM Score60.39
SENS Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.62 | -$0.63 | -1.34%(-$0.01) | |
| Q1 2026 | -$0.70 | -$0.71 | -1.14%(-$0.01) | |
| Q4 2025 | -$0.43 | -$0.46 | -6.10%(-$0.03) | |
| Q3 2025 | -$0.40 | -$0.43 | -6.65%(-$0.03) | |
| Q2 2025 | -$0.40 | -$0.40 | +0.00%(+$0.00) |
SENS Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
3.77
3.77
3.77
3.77
Industry Peers — Industrial Instruments(16)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
SENSSenseonics Holdings, Inc. Common Stock | D | A | B | 8.5x | 48.1% | 54.9% | -223.2% | $7.77 |
| DHRDanaher Corporation | D | C | B | 6.4x | 2.0% | 58.6% | 20.4% | $229.04 |
| AMEAmetek, Inc. | D | C | B | 7.2x | 10.3% | 36.9% | 25.6% | $248.17 |
| KEYSKeysight Technologies, Inc. | D | B | B | 8.6x | 5.0% | 64.7% | 20.3% | $331.21 |
| ROPRoper Technologies, Inc. Common Stock | C | B | B | 4.6x | 14.5% | 69.5% | 28.0% | $382.71 |
| FTVFortive Corporation | C | D | B | 4.0x | -2.1% | 63.2% | 18.2% | $57.79 |
| MKSIMKS Inc. Common Stock | C | B | C | 3.3x | 11.0% | 47.0% | 15.4% | $214.83 |
| CGNXCognex Corp | D | C | C | 8.3x | 4.2% | 68.9% | 21.8% | $53.99 |
| RALRalliant Corporation | C | C | B | 3.4x | — | 50.9% | -53.3% | $66.55 |
| STSensata Technologies Holding plc | B | D | B | 1.6x | 4.0% | 29.5% | 7.6% | $40.58 |
| MLABMesa Laboratories Inc | C | D | A | 2.7x | 13.2% | 64.2% | 9.0% | $122.48 |
About Senseonics Holdings, Inc. Common Stock
Senseonics Holdings is a medical technology company specializing in long-term implantable continuous glucose monitoring systems designed to help diabetes patients manage their condition. The company's integrated platform includes implantable sensors, smart transmitters, and a mobile application. The majority of its revenue is generated from international markets outside the United States.